<DOC>
	<DOCNO>NCT01767298</DOCNO>
	<brief_summary>This study conduct compare rate extent absorption valsartan hydrochlorothiazide . To maximize possibility find drug-drug interaction , dose valsartan hydrochlorothiazide double ( 320 mg VAL 25 mg HCT ) .</brief_summary>
	<brief_title>Pharmacokinetic Interactions Valsartan Hydrochlorothiazide ( Double Doses )</brief_title>
	<detailed_description />
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>At least 18 year old 45 healthy male volunteer Actual weight Â± 30 % ideal body weight base sex , height , body frame Who pass screen parameter Free drug exposure know interfere pharmacokinetics assay fexofenadine least 10 day prior study Who able communicate effectively study personnel , literate , able give consent . A clinically significant abnormal physical exam , medical history , laboratory study If show sit SBP &gt; 140 &lt; 100 mmHg , DBP &gt; 90 &lt; 60mm Hg , pulse rate &gt; 95 &lt; 50 beats/min screen A history serious intolerance , allergy , sensitivity fexofenadine The use prescription drug within previous month use overthecounter medication ( exception acetaminophen ) within past 14 day A history blood dyscrasias A history alcohol drug abuse within past year Donation blood 8 week prior study plan donate blood within 8 week complete study Unable tolerate vein puncture multiple blood sampling Any surgical/medical condition might alter drug absorption , distribution , metabolism , excretion Can follow instruction , opinion investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Fixed dose combination</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Valsartan</keyword>
	<keyword>Hydrochlorothiazide</keyword>
</DOC>